The Alianne Story

Alianne Asset Management was founded in 2016 and named after the late grandmother of our founder and current CEO Dimitry Alriche. Dimitry who was raised in the impoverished nation of Haiti was privileged to be raised by his loving grandmother who taught him the measure of hard work and instilled great values which he has applied to the vision of Alianne.

Alianne Asset began as an investment firm providing wealth management services in the futures and foreign exchange markets, and has since expanded its team and operations to include a marketing firm helping medical practitioners grow using digital marketing assets, and a trading academy teaching many people how to manage their own capital in the financial markets. The Alianne Asset Management Group has three specialties which we do well and with great dignity.

Technological Reliability

servers

The servers we use are highly reliable, running 24 hours a day with 99.999% uptime. We use algorithms to manage the entire trade cycle of our portfolios from the point of entry, to liquidation and therefore we need to be connected all the time. Our clients can rest well knowing that this technology is amongst the best and most reliable in the world, which truly enables them to Invest with Confidence.

Market Watch

Currency Rates

InstrumentBidAskHighLow
EURUSD 1.21192 1.21207 1.21236 1.2117
USDJPY 110.068 110.088 110.092 110.059
GBPUSD 1.41059 1.41141 1.41246 1.40997
USDCHF 0.89932 0.90027 0.90053 0.8992
...

Updated 2021-06-14 22:00:01 UTC

Market News

Biotech Century Therapeutics to offer 10.6 million shares in IPO, priced at $18 to $20 each

Mon, 14 Jun 2021 21:26:23 GMT

Biotech Century Therapeutics Inc. set terms for its initial public offering on Monday, with plans to offer 10.6 million shares priced at $18 to $20 each. The company has applied to list on Nasdaq, under the ticker symbol "IPSC." JP Morgan, BofA Securities, SVB Leerink and Piper Sandler are underwriting the deal. Proceeds will be used to fund pre-clinical activity and research and development, as well as working capital and general corporate purposes. "We are an innovative biotechnology company developing transformative allogeneic cell therapies to create products for the treatment of both solid tumor and hematological malignancies with significant unmet medical need," the company says in its prospectus.

read more

Telehealth company Hims & Hers to buy U.K.'s Honest Health

Mon, 14 Jun 2021 20:45:49 GMT

Telehealth company Hims & Hers Health Inc. said late Monday it has agreed to buy London-based health platform Honest Health for an undisclosed amount. Honest Health offers hair loss-related products, including access to compounded products. "The proposed transaction provides Hims & Hers with best-in-class operational capability and infrastructure to support the beginnings of the company's long-term plans for expansion" across the U.K. and western Europe, Hims and Hers said in a statement. The deal is expected to close in the second fiscal quarter of this year, the company said. Shares of Hims and Hers fell 0.6% in the extended session Monday after ending the regular trading day up 5.7%. The stock began trading in January after a merger with a blank-check company.

read more

FedEx raises dividend by 15%

Mon, 14 Jun 2021 20:23:00 GMT

FedEx Corp. said late Monday its board has approved a 15% increase to the delivery and logistics company's dividend. The dividend, up by 10 cents to 75 cents a share, is payable July 12 to stockholders of record as of June 28. "Increasing our dividend reinforces our commitment to drive value for shareowners," Chief Financial Officer Michael C. Lenz said in a statement. "Our balance sheet and cash flow allow us to strategically invest in long-term, profitable growth while also rewarding our shareowners by raising our dividend." FedEx shares traded 0.3% higher in the extended session Monday after ending the regular trading day down 1.1%.

read more

Nasdaq, S&P 500 end at records, Dow drops as investors await Fed

Mon, 14 Jun 2021 20:08:03 GMT

Stocks posted a mixed finish Monday, with the Nasdaq Composite scoring its first record close since April 26 and the S&P 500 eking out its third consecutive record as the Dow Jones Industrial Average lost ground. The Dow ended with a loss of around 86 points, or 0.2%, near 34,394, according to preliminary figures. The S&P 500 gained around 8 points, or 0.2%, to close near 4,255. The Nasdaq rose around 130 points, or 0.9%, to finish near 14,174, surpassing its previous record of 14,138.76 set on April 26. Investors are awaiting the outcome Wednesday of a two-day Federal Reserve meeting, hoping for clues to plans around the eventual tapering of asset purchases in the face of rising inflation.

read more

U.S. oil futures edge lower as traders eye demand

Mon, 14 Jun 2021 18:57:29 GMT

U.S. oil futures settled slightly lower on Monday as traders continued to eye prospects for energy demand. In a report issued last week, the International Energy Agency said it expects oil demand to return to pre-pandemic levels before the end of 2022, and that's "ahead of previous predictions," said Michael Hewson, chief market analyst at CMC Markets UK. "Vehicle use is starting to return to pre-pandemic use in the U.S. and Canada, while in the U.K. it already has returned to levels just prior to the pandemic, as less people use public transport and use their own vehicles to move around," he said. "While this is likely to see higher gasoline demand, this should be offset to some extent by lower demand for aviation fuel due to there being less air travel." Meanwhile, "talk of Iranian sanctions being lifted may well be acting as a bit of a headwind" for oil prices, Hewson said. West Texas Intermediate oil for July delivery fell 3 cents, or 0.04%, to settle at $70.88 a barrel on the New York Mercantile Exchange after trading as high as $71.78.

read more
More News...